UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

British journal of cancer, 2014-11, Vol.111 (10), p.1909-1916

2014

Volltextzugriff (PDF)

A Phase I Study of the Pharmacokinetic and Safety Profiles of Oral Pazopanib With a High-Fat or Low-Fat Meal in Patients With Advanced Solid Tumors

Clinical pharmacology and therapeutics, 2010-12, Vol.88 (6), p.818-823

2010

Volltextzugriff (PDF)

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies

British journal of cancer, 2014-05, Vol.110 (11), p.2647-2654

2014

Volltextzugriff (PDF)

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study

British journal of cancer, 2014-02, Vol.110 (4), p.888-893

2014

Volltextzugriff (PDF)

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

CPT: pharmacometrics and systems pharmacology, 2015-11, Vol.4 (11), p.660-668

2015

Volltextzugriff (PDF)

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.652-659

2010

Volltextzugriff (PDF)

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

British journal of cancer, 2014-12, Vol.111 (12), p.2383-2383

2014

Volltextzugriff (PDF)

Comparison of zafirlukast (Accolate®) absorption after oral and colonic administration in humans

Pharmaceutical research, 2000-02, Vol.17 (2), p.154-159

2000

Volltextzugriff (PDF)

Regional gastrointestinal absorption of ranitidine in the rat

Pharmaceutical research, 1995-09, Vol.12 (9), p.1311-1315

1995

Volltextzugriff (PDF)

Gastrointestinal transit and distribution of ranitidine in the rat

Pharmaceutical research, 1995-09, Vol.12 (9), p.1316-1322

1995

Volltextzugriff (PDF)

Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles

Pharmaceutical research, 1992-03, Vol.9 (3), p.350-356

1992

Volltextzugriff (PDF)

Erratum: Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

British journal of cancer, 2014-12, Vol.111 (12), p.2383-2383

2014

Volltextzugriff (PDF)

Changes in polyvinylpyrrolidone coil dimensions by complexation with organic anions : effect of chain length

Colloid and polymer science, 1991-07, Vol.269 (7), p.643-649

1991

Volltextzugriff (PDF)

Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2040-2040

2009

Volltextzugriff (PDF)

A phase I study of pazopanib in patients with advanced hepatocellular carcinoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3561-3561

2009

Volltextzugriff (PDF)

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor ReceptorTyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Clinical pharmacology and therapeutics, 2010, Vol.88 (5), p.652-659

2010

Volltextzugriff (PDF)

A phase I, open-label study of the safety and pharmacokinetics (PK) of pazopanib (P) and lapatinib (L) administered concurrently

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3088-3088

2006

Volltextzugriff (PDF)

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3054-3054

2004

Volltextzugriff (PDF)

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3054-3054

2004

Volltextzugriff (PDF)

The absolute bioavailability of oral vinorelbine in patients with solid tumors

Cancer chemotherapy and pharmacology, 2005-12, Vol.56 (6), p.578-584

2005

Volltextzugriff (PDF)

A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)

Cancer chemotherapy and pharmacology, 2003, Vol.51 (1), p.58-66

2003

Volltextzugriff (PDF)

Biodiversity and Resilience of Ecosystem Functions

Trends in ecology & evolution (Amsterdam), 2015-11, Vol.30 (11), p.673-684

2015

Volltextzugriff (PDF)

Species Interactions Reverse Grassland Responses to Changing Climate

Science (American Association for the Advancement of Science), 2007-02, Vol.315 (5812), p.640-642

2007

Volltextzugriff (PDF)

Active and diverse viruses persist in the deep sub-seafloor sediments over thousands of years

The ISME Journal, 2019-07, Vol.13 (7), p.1857-1864

2019

Volltextzugriff (PDF)

Comparing biodiversity offset calculation methods with a case study in Uzbekistan

Biological conservation, 2014-10, Vol.178, p.2-10

2014

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)

Publikationsform

Sprache

Englisch
(145)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(59)
Biological And Medical Sciences
(34)
Humans
(25)
Ecology
(24)
Environmental Sciences & Ecology
(20)
Medical Sciences
(18)
Animals
(16)
Biodiversity
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Physical Sciences
(16)
Male
(14)
Adult
(13)
Pharmacology. Drug Treatments
(12)
Biomedical And Life Sciences
(11)
Environmental Sciences
(11)
Pharmacology & Pharmacy
(11)
Chemistry
(10)
Female
(10)
Multidisciplinary Sciences
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

A Phase I Study of the Pharmacokinetic and Safety Profiles of Oral Pazopanib With a High-Fat or Low-Fat Meal in Patients With Advanced Solid Tumors

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

Comparison of zafirlukast (Accolate®) absorption after oral and colonic administration in humans

Regional gastrointestinal absorption of ranitidine in the rat

Gastrointestinal transit and distribution of ranitidine in the rat

Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles

Erratum: Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

Changes in polyvinylpyrrolidone coil dimensions by complexation with organic anions : effect of chain length

Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study

A phase I study of pazopanib in patients with advanced hepatocellular carcinoma

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor ReceptorTyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

A phase I, open-label study of the safety and pharmacokinetics (PK) of pazopanib (P) and lapatinib (L) administered concurrently

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

The absolute bioavailability of oral vinorelbine in patients with solid tumors

A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)

Biodiversity and Resilience of Ecosystem Functions

Species Interactions Reverse Grassland Responses to Changing Climate

Active and diverse viruses persist in the deep sub-seafloor sediments over thousands of years

Comparing biodiversity offset calculation methods with a case study in Uzbekistan

Aktive Filter

Suchergebnisse filtern